Latest news
Renaissance Technologies LLC Has $3.17 Million Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeatMarketBeat · Sun, 09 Aug 2026 08:43:59 GMTAutolus Therapeutics (AUTL) Institutional Ownership 2026 $AUTL - MarketBeatMarketBeat · Fri, 07 Aug 2026 07:00:00 GMTAutolus Therapeutics PLC (AUTL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTWatkins Advises Perceptive Advisors on Growth Financing for Leading Oncology Biotech Autolus Therapeutics - Latham & Watkins LLPLatham & Watkins LLP · Tue, 04 Aug 2026 16:34:38 GMTAutolus Raises AUCATZYL Outlook, Secures New Credit Facility - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 12:34:00 GMTAutolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026 - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 20:10:31 GMTAutolus Sets Aug. 11 Webcast for Q2 Results and Business Update - Stock TitanStock Titan · Mon, 03 Aug 2026 20:05:00 GMTCNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Othe - BenzingaBenzinga · Mon, 03 Aug 2026 14:00:46 GMT